Tao Yin

机构：Union Hospital, Chinese Academy of Sciences, Shanghai Library, China University of Geosciences (Beijing), Shanghai Institute of Materia Medica, Hainan General Hospital, Wuhan Union Hospital, Institute of Crop Sciences, Hubei Cancer Hospital, Union Hospital, University of Chinese Academy of Sciences, Huazhong University of Science and Technology · ORCID：0000-0002-1902-6302

发表论文 126 篇 · 总被引 5405 次 · h-index 37

代表论文

• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial (2023 · The Lancet · 被引 512)
• METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner (2023 · Cancer Letters · 被引 76)
• Breaking NGF–TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection (2024 · Nature Immunology · 被引 52)
• ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy (2023 · Genes & Development · 被引 34)
• Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons (2023 · Molecular Psychiatry · 被引 27)
• Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation (2023 · ACS Nano · 被引 27)